346 related articles for article (PubMed ID: 21154260)
1. Sex-based differences in clinical and angiographic outcomes in patients with ST-elevation myocardial infarction treated with concomitant use of glycoprotein IIb/IIIa inhibitors.
Kralev S; Hennig O; Lang S; Kälsch T; Borggrefe M; Dempfle CE; Süselbeck T
Cardiol J; 2010; 17(6):580-6. PubMed ID: 21154260
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of patients with diabetes presenting with ST-elevation myocardial infarction and treated with concomitant use of glycoprotein IIb/IIIa inhibitors.
Kralev S; Krause B; Papavassiliu T; Lang S; Haghi D; Kälsch T; Dempfle CE; Borggrefe M; Süselbeck T
Cardiol J; 2009; 16(3):234-40. PubMed ID: 19437397
[TBL] [Abstract][Full Text] [Related]
3. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
Saltzman AJ; Stone GW; Claessen BE; Narula A; Leon-Reyes S; Weisz G; Brodie B; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Metzger DC; Lansky AJ; Nikolsky E; Dangas GD; Mehran R
JACC Cardiovasc Interv; 2011 Sep; 4(9):1011-9. PubMed ID: 21939942
[TBL] [Abstract][Full Text] [Related]
4. Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors and BMS or DES.
De Luca G; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Carbone G; Pagliuca MR; Rosato G; Di Lorenzo E
J Thromb Thrombolysis; 2010 Aug; 30(2):133-41. PubMed ID: 19921102
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655
[TBL] [Abstract][Full Text] [Related]
6. Selective drug-eluting stent implantation for high-risk patients with acute ST-elevation myocardial infarction: rationale and safety.
Prasad SB; David T; Malaiapan Y; Cameron JD; Meredith IT
Catheter Cardiovasc Interv; 2011 Feb; 77(2):193-200. PubMed ID: 20549694
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial.
Jeger RV; Brunner-La Rocca HP; Hunziker PR; Tsakiris DA; Kaiser CA; Pfisterer ME;
Clin Ther; 2009 Dec; 31(12):2886-93. PubMed ID: 20110027
[TBL] [Abstract][Full Text] [Related]
8. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of glycoprotein IIb/IIIa receptor antagonists for patients undergoing percutaneous coronary intervention within twelve hours of fibrinolysis.
Belle L; Fourny M; Reynaud T; Hammer L; Vanzetto G; Labarère J;
Catheter Cardiovasc Interv; 2011 Sep; 78(3):376-84. PubMed ID: 21413113
[TBL] [Abstract][Full Text] [Related]
10. Safety and effectiveness of drug eluting stent in patients with ST elevation myocardial infarction undergoing primary angioplasty.
Romano M; Buffoli F; Tomasi L; Corrado L; Ferrari MR; Zanini R
Catheter Cardiovasc Interv; 2008 May; 71(6):759-63. PubMed ID: 18412066
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
Wijnbergen I; Tijssen J; van 't Veer M; Michels R; Pijls NH
Catheter Cardiovasc Interv; 2013 Sep; 82(3):379-84. PubMed ID: 23553888
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
[TBL] [Abstract][Full Text] [Related]
13. Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study.
Wijnbergen I; Helmes H; Tijssen J; Brueren G; Peels K; van Dantzig JM; Van' t Veer M; Koolen JJ; Pijls NH; Michels R
JACC Cardiovasc Interv; 2012 Mar; 5(3):313-22. PubMed ID: 22440498
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors.
De Luca G; Gibson CM; Bellandi F; Noc M; Dudek D; Zeymer U; Arntz HR; Cutlip D; Maioli M; Zorman S; Mesquita Gabriel H; Emre A; Rakowski T; Gyongyosi M; Huber K; Van't Hof AW
Atherosclerosis; 2009 Nov; 207(1):181-5. PubMed ID: 19426981
[TBL] [Abstract][Full Text] [Related]
15. In-hospital clinical outcome in elderly patients with acute myocardial infarction treated with primary angioplasty.
Tespili M; Guagliumi G; Valsecchi O; Musumeci G; Vassileva A; Saino A; Scuri PM; Gavazzi A
Ital Heart J; 2003 Mar; 4(3):193-8. PubMed ID: 12784746
[TBL] [Abstract][Full Text] [Related]
16. The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients.
Lavi S; Gruberg L; Kapeliovich M; Hammerman H; Boulos M; Grenadier E; Aronson D; Markiewicz W; Beyar R
J Invasive Cardiol; 2005 Jun; 17(6):296-9. PubMed ID: 16003002
[TBL] [Abstract][Full Text] [Related]
17. Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors.
De Luca G; Gibson M; Cutlip D; Huber K; Dudek D; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Secco GG; Mesquita Gabriel H; Emre A; Arntz HR; Rakowski T; Gyongyosi M; Hof AW;
Arch Cardiovasc Dis; 2013 Mar; 106(3):155-61. PubMed ID: 23582677
[TBL] [Abstract][Full Text] [Related]
18. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.
Pride YB; Mohanavelu S; Zorkun C; Kunadian V; Giugliano RP; Newby LK; Braunwald E; Califf RM; Harrington RA; Gibson CM;
JACC Cardiovasc Interv; 2012 Sep; 5(9):927-35. PubMed ID: 22995880
[TBL] [Abstract][Full Text] [Related]
19. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
20. Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents.
Nikolsky E; Holmes DR; Mehran R; Dangas G; Schampaert E; Morice MC; Schofer J; Sousa JE; Fahy M; Na Y; Donohoe DJ; Moses JW; Leon MB
Catheter Cardiovasc Interv; 2008 Jun; 71(7):896-906. PubMed ID: 18498145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
